Associate ProfessorBridget Stocker

Professor of Bio-Medical Chemistry

School of Chemical and Physical Sciences

  • Professor of Bio-Medical Chemistry
    School of Chemical and Physical Sciences
  • +6444636481 (Work)
  • LB 508, Laby Building, Gate 7, Kelburn Pde, Wellington, 6012, New Zealand

BIO

Bridget Stocker was awarded first class honours and the VUW University of Wellington Award and Medal for Academic Excellence for being the top BSc (hons) graduate within the VUW Science Faculty (2001). She then embarked on a Ph.D. in Organic Chemistry (VUW), under the supervision of Prof. John Hoberg where her research focussed on the total synthesis of the marine natural product, Peloruside A. Dr Stocker was then awarded a FRST-funded post-doctoral fellowship to study with Prof P. H. Seeberger (Swiss Federal Institute of Technology, Zurich), where she completed the synthesis of complex glycoconjugates, including several found in the cell wall of Mycobacterium Tuberculosis. In 2006, Bridget moved back to New Zealand and, within one year, obtained a position as a Group Leader at the Malaghan Institute of Medical Institute (MIMR). During this time, she honed her skills in immunology and, together with Dr Mattie Timmer (VUW), established the joint MIMR/VUW “Immunoglycomics Group – a research programme at the interface of chemistry and immunology. In 2013, Bridget obtained a position at VUW as a Senior Lecturer. She is presently an Associate Professor in Bioorganic Chemistry at VUW.

 

Bridget has received several awards and fellowships including the 2011 RSNZ Easterfield Medal (for the top emerging New Zealand chemist), a HRC Hercus Fellowship (2013), and HRC Consolidator Grant (2020), as well as several RSNZ Marsden grants and NIH funding. Her research focuses on the development of molecules that can activate innate and innate-like immune cells. Key areas of study include the development of vaccine adjuvants for both veterinary and human-health applications, cancer immunotherapies, and treatments of infectious diseases. Dr Stocker’s work has led to several patents and a license agreement with a US biotech company that will see adjuvants being used in human clinical trials. Other commercial applications of the immunomodulators developed within the Immunoglycomics group are currently being explored.

ACADEMIC POSITIONS

  • Group Leader
    Malaghan Institute of Medical Research, Immunoglycomics, Wellington, New Zealand2006 - 2013
  • Post-doctoral Fellow
    Malaghan Institute of Medical Research, New Zealand2006 - 2007
  • Post-doctoral Fellow
    ETH Zurich, Zurich, Switzerland2004 - 2006

NON-ACADEMIC POSITIONS

  • Co-chair (voluntary)
    Aro Valley Community Council, Wellington2011 - 2013

DEGREES

  • PhD (Chemistry)
    Victoria University of Wellington, New Zealand2004 - present
  • Hons (first class) Chemistry
    Victoria University of Wellington, New Zealand2001 - present
  • BSc (Chemistry, Chemistry and Technology)
    Victoria University of Wellington, New Zealand2000 - present
  • BCA (Management, Commercial Law)
    Victoria University of Wellington, New Zealand2000 - present

AVAILABILITY

  • Masters Research or PhD student supervision